Zhang Henrik, Tu Thomas
Storr Liver Centre, Westmead Clinical School and Westmead Institute for Medical Research, Faculty of Medicine and Health, The University of Sydney, Westmead, Australia.
Centre for Infectious Diseases and Microbiology, Marie Bashir Institute for Infectious Diseases and Biosecurity, The University of Sydney at Westmead Hospital, Westmead, Australia.
Clin Mol Hepatol. 2022 Apr;28(2):135-149. doi: 10.3350/cmh.2021.0283. Epub 2021 Oct 22.
Chronic hepatitis B is a major cause of liver disease worldwide and is currently incurable. Hepatitis B virus (HBV) covalently closed circular (ccc) DNA is a key form of the virus responsible for its persistence and is the transcriptional template for all viral transcripts. The field is focussed on methods to clear HBV cccDNA but this been limited by technical difficulties in its quantification due to: identical sequence to other forms of HBV DNA; low copy number per cell; and high resistance to denaturation by heat, leading to difficulty using polymerase chain reaction or hybridization methods for detection. A number of assays have been developed in order to overcome these hurdles either directly or detecting cccDNA levels indirectly via its transcriptional products. In this review, we summarize the approaches to cccDNA quantification that are currently used, and outline key open questions in the cccDNA biology field which remain to be answered due to the limitations of current methods.
慢性乙型肝炎是全球肝脏疾病的主要病因,目前无法治愈。乙型肝炎病毒(HBV)共价闭合环状(ccc)DNA是病毒持续存在的关键形式,也是所有病毒转录本的转录模板。该领域聚焦于清除HBV cccDNA的方法,但由于以下原因,其定量存在技术困难,限制了相关研究:与其他形式的HBV DNA序列相同;每个细胞中的拷贝数低;对热变性具有高抗性,导致难以使用聚合酶链反应或杂交方法进行检测。为了克服这些障碍,已经开发了许多检测方法,这些方法要么直接检测cccDNA水平,要么通过其转录产物间接检测。在本综述中,我们总结了目前用于cccDNA定量的方法,并概述了cccDNA生物学领域中由于当前方法的局限性而仍有待解答的关键开放性问题。